For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and… Read more
Category: lung cancer
New Technology Significantly Improves Lung Cancer Surgery
Researchers at UPMC and the University of Pittsburgh School of Medicine are using groundbreaking tumor-highlighting technology to better visualize lung cancer tissue—giving surgeons a significantly… Read more
Wisconsin Native with CF Finds Silver Lining Through Lung Transplant at UPMC
Bobby Perron, of New Berlin, Wisconsin, spent many years of his life sick from cystic fibrosis, a genetic disease that causes thick mucus to form… Read more
Lifesaving First in Medicine Boosted by Student Research in Hatfull Lab
Last summer, undergraduate research assistant Gabrielle Gentile watched her colleagues in the University of Pittsburgh Hatfull Lab work diligently to identify viruses that could infect and kill… Read more
After double lung transplant, Pittsburgh woman ready to live again
Given her family’s health history, Sarah Mercer knew she might be at risk for idiopathic pulmonary fibrosis (IPF). That’s why when she was hospitalized for… Read more